Abstract
Bacterial infections in sickle cell disease (SCD) are associated with major risks of morbidity and mortality. Here, we describe the occurrence of bacteremia in SCD patients from 2000 to 2017. This is an observational study which included children and adults with SCD and fever and had confirmed positive blood cultures. During the study period, there were 1095 SCD patients with 17,053 blood cultures. Of all the patients, 699 (63.8%) were children and 396 (36.2%) adults with 576 (52.6%) males and 519 (47.4%) females. The mean age ± SD was 17.8 (± 14.7), and a median age (IQR) of 13.6 (6.8–23.5) years. The mean (SD) follow up was 7.4 (5.4) years and the total number of patient-years was 8069.1 years. Out of the 1095 patients, 91 (8.3%) had bacteremia with 35 (38.5%) children and 65 (61.5%) adults (p = .079). The rate of bacteremia in all patients, children, and adults were 1.5 (95% CI: 1.3–1.8), 0.6 (95% CI: 0.4–0.8), and 2.4 (95% CI: 1.8–3.1) per 100 patient-years, respectively. The risk of Gram-positive bacteremia was 0.5 (96% CI: 0.36–0.69) in all patients, 0.1 (95% CI: 0.06–0.20) in children, and 1.4 (95% CI: 1.0–2.0) in adults per 100 patient-years. The risk of Gram-negative bacteremia was 1.0 (95% CI: 0.81–1.3) in all patients, 0.6 (95% CI: 0.4–0.8) in children, and 2 (95% CI: 1.5–2.7) in adults per 100 patient-years. The risk of Gram-negative bacteremia was higher than Gram-positive bacteremia in children (p < .001) but not in adults (p = .113) and adults had higher risk in general than children. In this study of SCD cohort, 8.3% had bacteremia with predominant Gram-negative infections. Bacteremia was more frequently encountered in the adult age group. Further studies are needed to verify the findings and explore possible reasons predisposing SCD patients to bacteremia.
Similar content being viewed by others
Data Availability
Data is available from the corresponding author upon request.
References
Al-Mendalawi MD (2009) The prevalence of sickle cell anemia in Saudi children and adolescents. A community-based survey. Saudi Med J 30:452
Al-Qurashi MM, El-Mouzan MI, Al-Herbish AS et al (2008) The prevalence of sickle cell disease in Saudi children and adolescents. A community-based survey. Saudi Med J 29:1480–1483
AlHamdan NAR, AlMazrou YY, AlSwaidi FM, Choudhry AJ (2007) Premarital screening for thalassemia and sickle cell disease in Saudi Arabia. Genet Med 9:372–377. https://doi.org/10.1097/GIM.0b013e318065a9e8
Padmos MA, Sackey K, Roberts GT, Kulozik A, Bail S, Morris JS, Serjeant BE, Serjeant GR (1991) Two different forms of homozygous sickle cell disease occur in Saudi Arabia. Br J Haematol 79:93–98. https://doi.org/10.1111/j.1365-2141.1991.tb08013.x
Serjeant GR (1994) The geography of sickle cell disease: opportunities for understanding its diversity. Ann Saudi Med 14:237–246
Adamkiewicz TV, Sarnaik S, Buchanan GR, Iyer RV, Miller ST, Pegelow CH, Rogers ZR, Vichinsky E, Elliott J, Facklam RR, O'Brien KL, Schwartz B, van Beneden CA, Cannon MJ, Eckman JR, Keyserling H, Sullivan K, Wong WY, Wang WC (2003) Invasive pneumococcal infections in children with sickle cell disease in the era of penicillin prophylaxis, antibiotic resistance, and 23-valent pneumococcal polysaccharide vaccination. J Pediatr 143:438–444. https://doi.org/10.1067/S0022-3476(03)00331-7
Booth C, Inusa B, Obaro SK (2010) Infection in sickle cell disease: a review. Int J Infect Dis 14:e2–e12
Chulamokha L, Scholand SJ, Riggio JM, Ballas SK, Horn D, DeSimone JA (2006) Bloodstream infections in hospitalized adults with sickle cell disease: a retrospective analysis. Am J Hematol 81:723–728
Ellison AM, Ota KV, McGowan KL, Smith-Whitley K (2013) Epidemiology of bloodstream infections in children with sickle cell disease. Pediatr Infect Dis J 32:560–563. https://doi.org/10.1097/INF.0b013e318286c75b
Zarrouk V, Habibi A, Zahar JR, Roudot-Thoraval F, Bachir D, Brun-Buisson C, Legrand P, Godeau B, Galacteros F, Lesprit P (2006) Bloodstream infection in adults with sickle cell disease: association with venous catheters, staphylococcus aureus, and bone-joint infections. Medicine (Baltimore) 85:43–48. https://doi.org/10.1097/01.md.0000197023.46846.1c
Baskin MN, Goh XL, Heeney MM, Harper MB (2013) Bacteremia risk and outpatient management of febrile patients with sickle cell disease. Pediatrics 131:1035–1041. https://doi.org/10.1542/peds.2012-2139
West TB, West DW, Ohene-Frempong K (1994) The presentation, frequency, and outcome of bacteremia among children with sickle cell disease and fever. Pediatr Emerg Care 10:141–143. https://doi.org/10.1097/00006565-199406000-00005
Sirigaddi K, Aban I, Jantz A, Pernell BM, Hilliard LM, Bhatia S, Lebensburger JD (2018) Outcomes of febrile events in pediatric patients with sickle cell anemia. Pediatr Blood Cancer 65:e27379. https://doi.org/10.1002/pbc.27379
Bansil NH, Kim TY, Tieu L, Barcega B (2013) Incidence of serious bacterial infections in febrile children with sickle cell disease. Clin Pediatr (Phila) 52:661–666. https://doi.org/10.1177/0009922813488645
West DC, Andrada E, Azari R, Rangaswami AA, Kuppermann N (2002) Predictors of bacteremia in febrile children with sickle cell disease. J Pediatr Hematol Oncol 24:279–283. https://doi.org/10.1097/00043426-200205000-00012
Wilimas JA, Flynn PM, Harris S, Day SW, Smith R, Chesney PJ, Rodman JH, Eguiguren JM, Fairclough DL, Wang WC (1993) A randomized study of outpatient treatment with ceftriaxone for selected febrile children with sickle cell disease. N Engl J Med 329:472–476. https://doi.org/10.1056/nejm199308123290705
Rogers ZR, Morrison RA, Vedro DA, Buchanan GR (1990) Outpatient management of febrile illness in infants and young chlidren with sickle cell anemia. J Pediatr 117:736–739. https://doi.org/10.1016/S0022-3476(05)83330-X
Gaston MH, Verter JI, Woods G, Pegelow C, Kelleher J, Presbury G, Zarkowsky H, Vichinsky E, Iyer R, Lobel JS, Diamond S, Holbrook CT, Gill FM, Ritchey K, Falletta JM, For the Prophylactic Penicillin Study Group (1986) Prophylaxis with oral penicillin in children with sickle cell anemia. N Engl J Med 314:1593–1599. https://doi.org/10.1056/nejm198606193142501
McIntosh S, Rooks Y, Ritchey AK, Pearson HA (1980) Fever in young children with sickle cell disease. J Pediatr 96:199–204. https://doi.org/10.1016/S0022-3476(80)80802-X
Brown B, Dada-Adegbola H, Trippe C, Olopade O (2017) Prevalence and etiology of bacteremia in febrile children with sickle cell disease at a Nigeria tertiary hospital. Mediterr J Hematol Infect Dis 9:e2017039. https://doi.org/10.4084/mjhid.2017.039
Bala N, Chao J, John D, Sinert R (2019) Prevalence of bacteremia in febrile patients with sickle cell disease. Pediatr Emerg Care Publish Ah:1–6. https://doi.org/10.1097/pec.0000000000001944
Bello N, Kudu ATD, Adetokun AB et al (2018) Characterization and antimicrobial susceptibility profile of bacteraemia causing pathogens isolated from febrile children with and without sickle cell disease in Kano, Nigeria. Mediterr J Hematol Infect Dis 10:e2018016. https://doi.org/10.4084/mjhid.2018.016
Morrissey BJ, Bycroft TP, Almossawi O, Wilkey OB, Daniels JG (2015) Incidence and predictors of bacterial infection in febrile children with sickle cell disease. Hemoglobin 39:316–319. https://doi.org/10.3109/03630269.2015.1065419
Alsaif M, Robinson J, Abdulbaqi M, Aghbari M, al Noaim K, Alabdulqader M (2020) Prevalence of serious bacterial infections in children with sickle cell disease at King Abdulaziz Hospital, Al Ahsa. Mediterr J Hematol Infect Dis 13:e2021002. https://doi.org/10.4084/mjhid.2021.002
Williams TN, Uyoga S, Macharia A, Ndila C, McAuley CF, Opi DH, Mwarumba S, Makani J, Komba A, Ndiritu MN, Sharif SK, Marsh K, Berkley JA, Scott JAG (2009) Bacteraemia in Kenyan children with sickle-cell anaemia: a retrospective cohort and case-control study. Lancet 374:1364–1370. https://doi.org/10.1016/S0140-6736(09)61374-X
Platt OS, Brambilla DJ, Rosse WF, Milner PF, Castro O, Steinberg MH, Klug PP (1994) Mortality in sickle cell disease–life expectancy and risk factors for early death. N Engl J Med 330:1639–1644. https://doi.org/10.1056/nejm199406093302303
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Ethics approval
The study was approved by the JHAH IRB (#19-22).
Informed consent
This is not applicable as this is a retrospective study.
Conflict of interest
The authors declare no competing interests.
Additional information
Publisher’s note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
About this article
Cite this article
Al-Tawfiq, J.A., Rabaan, A.A. & AlEdreesi, M.H. Frequency of bacteremia in patients with sickle cell disease: a longitudinal study. Ann Hematol 100, 1411–1416 (2021). https://doi.org/10.1007/s00277-021-04523-x
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00277-021-04523-x